Skip to main content
Clinical Trials/NCT06346132
NCT06346132RecruitingNot Applicable

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation: a Randomized, Controlled Trial.

Schlotterbeck Hervé1 site in 1 country150 target enrollmentStarted: March 29, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
150
Locations
1
Primary Endpoint
Global pain intensity experienced during the procedure.

Study Overview

Brief Summary

The purpose of this study is to assess the effect on patient's comfort of a virtual reality experience during a procedure of cardiac electronic device implantation under local anesthesia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients over 18 year old,
  • Patients who signed the consent form and accepted to participate to the trial,
  • New cardiac electronic device implantation or cardiac electronic device battery change,
  • Surgical procedure planned in ambulatory care.

Exclusion Criteria

  • Communication limitations,
  • Surgical procedure planned in sedation or narcosis,
  • Severe sensorial deficits (visual, auditory),
  • Claustrophobia,
  • Known motion sickness,
  • Patient isolated or with contact precautions,
  • Known or anticipated psychiatric diseases,
  • Patient known for epilepsia,
  • Opened scar and or ongoing infection at the level of the face and/or eyes,
  • Patient evaluated non suitable for the study by the surgeon, cardiologist or anesthetist.

Outcomes

Primary Outcomes

Global pain intensity experienced during the procedure.

Time Frame: At the end of surgery

Global pain intensity experienced during the procedure evaluated with the Visual Analogue Scale (VAS).

Secondary Outcomes

  • Need for supplementary sedation and/or analgesia during the procedure.(At the end of surgery)
  • Total dose of local anaesthetic used during the procedure.(At the end of surgery)
  • Change in anesthetic strategy during procedure.(At the end of surgery)
  • Global anxiety intensity experienced during the procedure.(At the end of surgery)
  • Patient's perceived procedure duration.(At the end of surgery)
  • Incidence of hypotensive or hypoxic events during procedure.(At the end of surgery)
  • Interruption of virtual reality experience during the procedure.(At the end of surgery)
  • Patient's comfort during the procedure assessed by the surgeon and cardiologist.(At the end of surgery)
  • Maximal systolic arterial blood pressure.(At the end of surgery)
  • Incidence of motion sickness during the virtual reality experience.(At patient discharge (or at a maximum of 4 hours after the end of surgery))
  • Intra- and post-procedure complications.(At patient discharge (or at a maximum of 4 hours after the end of surgery))
  • Overall patient's comfort and satisfaction experienced during the procedure.(At patient discharge (or at a maximum of 4 hours after the end of surgery))

Investigators

Sponsor
Schlotterbeck Hervé
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Schlotterbeck Hervé

Principal Investigator

Ente Ospedaliero Cantonale, Bellinzona

Study Sites (1)

Loading locations...

Similar Trials

Effect of Virtual Reality on Patient's... | Clinical Trial